A Phase 1 Study of ADI-001: Anti-CD20 CAR-Engineered Allogeneic Gamma Delta1 (γδ) T Cells in Adults with B-Cell Malignancies

A Phase 1 Study of ADI-001: Anti-CD20 CAR-Engineered Allogeneic Gamma Delta1 (γδ) T Cells in Adults with B-Cell Malignancies

Saved in:
Bibliographic Details
Published in:Transplantation and cellular therapy Vol. 29; no. 2; pp. S15 - S16
Main Authors: Neelapu, Sattva S., Stevens, Don A., Hamadani, Mehdi, Frank, Matthew J., Holmes, Houston, Jacobovits, Aya, Hinkle, John, Kennedy-Wilde, Jackie, Maller, Ori, Weinstein, Bayarmagnai, Galimi, Francesco, Lai, Rose K, Miklos, David B.
Format: Journal Article
Language:English
Published: 01-02-2023
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2666-6367
2666-6367
DOI:10.1016/S2666-6367(23)00087-8